• Epalrestat: Redefining Neuroprotection and Translational Res

  2026-05-15

  This article offers translational researchers a deep-dive into the evolving role of Epalrestat, a high-purity aldose reductase inhibitor, in neurodegenerative and diabetic complication research. Drawing on new mechanistic insights—including competitive KEAP1 binding and Nrf2 pathway activation—this piece integrates evidence from recent landmark studies and strategic guidance for optimizing experimental design. It also situates Epalrestat within the competitive landscape, highlights APExBIO’s quality leadership, and delivers a forward-looking perspective on innovative research workflows.

• Simvastatin (Zocor): Advanced Workflows in Cancer & Lipid Re

  2026-05-15

  Simvastatin (Zocor) is transforming cholesterol and oncology research with robust, reproducible protocols and multiparametric phenotypic profiling. This guide delivers actionable workflow enhancements, troubleshooting strategies, and data-driven insights—empowering teams to unlock both established and emerging applications.

• Gut-Brain Cholinergic Pathway in B. fragilis–Mediated Seizur

  2026-05-14

  Jia et al. reveal that Bacteroides fragilis suppresses seizures through a gut-vagus-brain cholinergic signaling pathway involving colonic ChAT+ cells and acetylcholine neurotransmitter activity. Their translational study bridges animal models and clinical evidence, informing new microbiota-targeted strategies for pediatric refractory epilepsy.

• Simvastatin (Zocor) in Cancer & Lipidomics: Benchwork to Bre

  2026-05-14

  Simvastatin (Zocor) from APExBIO empowers researchers with robust inhibition of HMG-CoA reductase for transformative studies in cholesterol homeostasis and tumor biology. This guide details applied workflows, troubleshooting, and how machine learning phenotypic profiling refines mechanism-of-action discovery.

• (S)-(+)-Dimethindene maleate: Protocols for M2 Antagonist Re

  2026-05-13

  (S)-(+)-Dimethindene maleate addresses the need for a selective M2 muscarinic and H1 histamine receptor antagonist in autonomic regulation, cardiovascular, and respiratory function research. It is not recommended for diagnostic or clinical use and should be employed strictly in well-controlled laboratory workflows where receptor selectivity and solution stability are critical.

• ATM Inhibition and Metabolic Synergy in Ovarian Cancer Cells

  2026-05-13

  This study demonstrates that targeting the ATM kinase, a central regulator of homologous recombination-mediated DNA repair, can sensitize high grade serous ovarian cancer (HGSOC) cells to metabolic intervention with fenofibrate. The research provides mechanistic and empirical evidence for the synergistic induction of senescence in HR-proficient HGSOC cells, highlighting a promising therapeutic strategy for a patient subgroup with limited treatment options.

• Simvastatin (Zocor): Optimizing Lipid and Cancer Cell Assays

  2026-05-12

  Simvastatin (Zocor) from APExBIO is a cornerstone tool for dissecting cholesterol biosynthesis and anti-cancer pathways, with proven utility in both hepatic and prostate cancer models. This article delivers a practical, evidence-driven workflow, troubleshooting guidance, and actionable insights for researchers seeking robust, reproducible outcomes in lipid metabolism and oncology.

• Structure-Based Inhibitor Discovery for SARS-CoV-2 NSP15: In

  2026-05-12

  This study applied structure-based virtual screening to identify natural product inhibitors of SARS-CoV-2 NSP15, a viral endoribonuclease involved in immune evasion. Thymopentin and oleuropein emerged as stable, high-affinity inhibitors, offering new leads for antiviral research and combinatorial treatment strategies.

• 10 mM dNTP Mixture: Enabling Advanced DNA Synthesis & LNP As

  2026-05-11

  The 10 mM dNTP (2'-deoxyribonucleoside-5'-triphosphate) Mixture from APExBIO streamlines PCR, qPCR, DNA sequencing, and lipid nanoparticle (LNP) delivery research. Discover how its equimolar, pH-stable formulation boosts reproducibility, troubleshooting, and cutting-edge protocol performance.

• Lypressin Acetate: Mechanistic Insight and Translational Val

  2026-05-11

  This thought-leadership article explores the mechanistic depth and translational guidance surrounding Lypressin acetate, a lysine vasopressin analog distinguished by its precise G protein-coupled receptor targeting, robust quantitative data, and practical advantages in both classic and emerging research domains. We integrate peer-reviewed evidence and real-world workflow recommendations to provide actionable strategies for researchers navigating the complexities of diabetes insipidus modeling, vasoconstriction research, and antiviral studies, while highlighting the unique positioning of APExBIO's Lypressin acetate and bridging current knowledge to future opportunities.

• IWP-2 in Cancer Research: Precision PORCN Inhibition & Advan

  2026-05-10

  Explore how IWP-2, a potent Wnt production inhibitor, enables precision assay development and transformative insights in cancer research. This article uniquely connects molecular mechanism, assay optimization, and cross-disciplinary advances, offering practical guidance beyond standard protocol.

• High Viscosity Microenvironments Induce P-gp-Driven Chemores

  2026-05-09

  This study reveals that elevated extracellular fluid viscosity in the tumor microenvironment promotes chemoresistance by upregulating P-glycoprotein (P-gp) expression through a mechanotransduction pathway involving cytoskeletal remodeling, membrane tension, TRPV4 activation, and YAP signaling. These findings highlight the importance of considering mechanical cues in drug resistance research and suggest that targeting microenvironmental viscosity or its downstream signaling could improve cancer chemotherapy outcomes.

• Estradiol Benzoate: Applied Workflows for Estrogen Receptor

  2026-05-08

  Estradiol Benzoate, a high-purity synthetic estradiol analog, is a gold-standard tool for estrogen receptor alpha agonist studies. This article distills advanced use-cases, stepwise protocols, and troubleshooting strategies to maximize reproducibility and data fidelity in hormone receptor binding and signaling assays.

• Annexin V-FITC/PI Apoptosis Assay Kit: Workflow Answers & Da

  2026-05-08

  This article addresses common laboratory challenges in apoptosis detection using the Annexin V-FITC/PI Apoptosis Assay Kit (SKU K2003). Through scenario-driven Q&A, we analyze protocol optimization, data interpretation, and product reliability, providing actionable, evidence-based guidance for researchers and technicians. The article highlights reproducibility and workflow efficiency for SKU K2003, supporting confident adoption in apoptosis research.

• SB 431542: Precision ALK5 Inhibition in Vascular and Immunol

  2026-05-07

  Explore how SB 431542, a leading ALK5 inhibitor, enables advanced dissection of TGF-β signaling in vascular remodeling and anti-tumor immunology. This article delivers new insights for researchers seeking rigorous control over cell proliferation and migration.

16393 records 1/1093 page Next 12345 下5页 Last page